Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

HTTPS

Secure .gov websites use HTTPS
A lock (LockA locked padlock) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • About HHS
  • MAHA in Action
  • Programs & Services
  • Grants & Contracts
  • Laws & Regulations
  • Radical Transparency
  • About Us
  • Featured Priorities
  • National Vaccine Advisory Committee
  • Vaccines National Strategic Plan
Breadcrumb
  1. HHS
  2. Vaccines and Immunizatio…
  3. National Vaccine Advisor…
  4. National Vaccine Advisor…
  5. NVAC 2022 Meetings
  6. June 15-16, 2022 NVAC Meeting
  • National Vaccine Advisory Committee (NVAC)
    • Meetings
      • 2024 Meetings
      • 2023 Meetings
      • 2022 Meetings
      • 2021 Meetings
      • 2020 Meetings
      • 2019 Meetings
    • Reports & Recommendations
    • Members
      • Membership
    • Subcommittees
    • Charter

June 15-16, 2022 NVAC Meeting

June 15, 2022 - June 16, 2022

Watch Meeting Recap

Federal Register Notice

Meeting Minutes*

*People using assistive technology may not be able to fully access information in these files. For assistance, contact the HHS Office of Infectious Disease and HIV/AIDS Policy by emailing Ann.Aikin@hhs.gov.

June 2022 NVAC Meeting: Agenda

The Great Hall in the Hubert H. Humphrey Building
200 Independence Ave, SW, Washington, DC 20201
June 15-16, 2022

June 15, 2022

Time Agenda Item Watch Meeting Online
9:00 am – 9:05 am

CALL TO ORDER AND RULES OF ENGAGEMENT
Ann Aikin, Acting Designated Federal Official, NVAC

Watch at start
9:05 am – 9:15 am OPENING REMARKS
ADM Rachel Levine, Assistant Secretary of Health, OASH
Watch at 5:52
9:15 am – 9:20 am CHAIR’S WELCOME
Dr. Robert Hopkins, NVAC Chair
Watch at 20:00
9:20 am – 10:00 am

THE VACCINE CONFIDENCE SUBCOMMITTEE REPORT OUT
Dr. John Dunn
, Chair of the Vaccine Confidence Subcommittee

Watch at 24:46
10:00 am – 11:00 am

INNOVATION AND PRIORITIZATION FOR VACCINATION

  • Dr. Nicole Lurie, CEPI
  • Dr. Anna Taddio, Gavi, the Vaccine Alliance
  • Dr. Timothy Jinks, Wellcome Trust
Watch at 58:24
11:00 am – 11:15 am

BREAK

 
11:15 am – 12:00 pm

INNOVATIONS FOR IMMUNITY: INFANTS, IMMUNOCOMPROMISED PERSONS, AND THE ELDERLY

  • Dr. James Mayne, Pharmaceutical Research and Manufacturers of America
  • Dr. Greg Poland, Mayo Clinic
  • Dr. David Dowling, Boston Children’s Hospital
  • Dr. Nicholas Wohlgemuth, Kansas Health Science Center
Watch at start
12:00 pm – 1:15 pm

LUNCH

 
1:15 pm – 2:00 pm

UNFINISHED TRIUMPHS: FOUR DEVELOPMENTAL VACCINES FOR POVERTY-ASSOCIATED DISEASES

  • Dr. Emily Coates, NIH
  • Dr. Ramaswamy Kalyanasundaram, University of Illinois
  • Dr. Lou Bourgeois, PATH
  • Dr. Afzal Siddiqui, Texas Tech University
Watch at start
2:00 pm – 3:00 pm

STAYING FOCUSED: HIV VACCINE PURSUITS

  • Dr. Mitchell Warren, AVAC
  • Dr. Mary Marovich, National Institutes of Health
  • COL Julia Ake, Military HIV Research Program
  • Dr. Jesse Clark, University of California, Los Angeles

Watch at 1:10:54

3:00 pm – 3:15 pm

BREAK

 
3:15 pm – 3:30 pm

INVESTIGATING SEVERE HEPATITS IN CHILDREN
Dr. David Sugerman
, CDC

Watch at start
3:30 pm – 4:15 pm

HELP ELIMINATING THE SILENT EPIDEMIC IN AMERICA: NEW ADULT HEPATITIS B IMMUNIZATION RECOMMENDATIONS

  • Dr. Chari Cohen, Hepatitis B Foundation
  • Dr. Mark Weng, Centers for Disease Control and Prevention
  • Dr. Rita Kuwahara, Georgetown University
  • Dr. Carolyn Bridges, Immunization Action Coalition
 
4:15 pm – 5:15 pm

MOVING THE NEEDLE: INJECTION-FREE INOCULATIONS

  • Dr. Myron Levine, University of Maryland
  • Dr. David Fernandez Rivas, Massachusetts Institute of Technology
  • Dr. Gunilla Jacobson, Stanford University
  • Dr. Shaomin Tian, University of North Carolina at Chapel Hill
  • Dr. Jillian Perry, University of North Carolina at Chapel Hill
  • Dr. Darrell Irvine, Massachusetts Institute of Technology
 
5:15 pm – 5:30 pm

PUBLIC COMMENT

 
5:30 pm

ADJOURN

 

 

June 16, 2022

 

Time Agenda Item Watch Meeting Online
9:00 am – 9:05 am

CALL TO ORDER AND RULES OF ENGAGEMENT
Ann Aikin, Acting Designated Federal Official, NVAC

 
9:05 am – 9:15 am CHAIR’S WELCOME
Dr. Robert Hopkins, NVAC Chair
Watch at start
9:15 am – 10:00 am

EASING COLD CHAIN CONSIDERATIONS

  • Dr. Julie Swann, North Carolina State University
  • Dr. Anna Nagurney, University of Massachusetts Amherst
  • Joanie Robertson, PATH
Watch at 8:22
10:00 am – 10:15 am BREAK  
10:15 am – 11:15 am COVID-19 VACCINE SAFETY REVIEW
  • Dr. Robert Hopkins, National Vaccine Advisory Committee
  • Dr. Nicola Klein, Kaiser Permanente Vaccine Study Center
  • Dr. John Beigel, National Institutes of Health
  • Dr. Robert Kaplan, Stanford University
Watch at start
11:15 am – 11:45 am MONKEYPOX 2022: U.S. SITUATION SUMMARY
Dr. Brett Peterson, Centers for Disease Control and Prevention
Watch at 59:24
11:45 am – 12:15 pm

A PARADIGM SHIFT: IMPROVING REPRESENTATION IN CLINICAL TRIALS

  • Dr. Carlos del Rio, Emory University
  • Dr. Zeke McKinney, HealthPartners
Watch at 1:35:28
12:15 pm – 1:15 pm LUNCH  
12:15 pm – 1:15 pm FEDERAL AGENCY UPDATES Watch at start
12:15 pm – 1:15 pm LIAISION REPRESENTATIVE UPDATES Watch at 15:19
2:15 pm – 2:30 pm

PUBLIC COMMENT

 
2:30 pm

ADJORN MEETING

 
Content created by Office of Infectious Disease and HIV/AIDS Policy (OIDP)
Content last reviewed April 3, 2023
Back to top
Secretary Robert F. Kennedy Jr.

Follow @SecKennedy

HHS icon

Follow @HHSGov

HHS Email updates

Receive email updates from HHS.

Subscribe

HHS Logo

HHS Headquarters

200 Independence Avenue, S.W.
Washington, D.C. 20201
Toll Free Call Center: 1-877-696-6775​

  • Contact HHS
  • Careers
  • HHS FAQs
  • Nondiscrimination Notice
  • Press Room
  • HHS Archive
  • Accessibility Statement
  • Privacy Policy
  • Budget/Performance
  • Inspector General
  • Web Site Disclaimers
  • EEO/No Fear Act
  • FOIA
  • The White House
  • USA.gov
  • Vulnerability Disclosure Policy